Low-Molecular-Weight Heparins
- 28 July 1998
- journal article
- editorial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 98 (4), 287-289
- https://doi.org/10.1161/01.cir.98.4.287
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery DiseaseCirculation, 1997
- Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic PlaquesCirculation, 1997
- Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemiaJournal of the American College of Cardiology, 1995
- The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparinBlood Coagulation & Fibrinolysis, 1995
- Thrombin hypothesis of thrombus generation and vascular lesion formationThe American Journal of Cardiology, 1995
- Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.Circulation, 1994
- Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.JCI Insight, 1991
- Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarctionJournal of the American College of Cardiology, 1990